Marshall Wace, LLP Scholar Rock Holding Corp Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 2,945,408 shares of SRRK stock, worth $109 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,945,408

Previous 212,862 1283.72%

Holding current value

$109 Million

Previous $1.71 Million 7366.28%

% of portfolio

0.16%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$7.07 - $45.73 $19.3 Million - $125 Million	2,732,546 Added 1283.72%	2,945,408 $127 Million
Q3 2024 Nov 14, 2024	SELL	$7.63 - $9.71 $2.09 Million - $2.66 Million	-274,423 Reduced 56.32%	212,862 $1.71 Million
Q2 2024 Aug 14, 2024	BUY	$7.84 - $16.79 $3.49 Million - $7.47 Million	444,961 Added 1051.32%	487,285 $4.06 Million
Q1 2024 May 15, 2024	BUY	$13.2 - $17.76 $558,676 - $751,674	42,324 New	42,324 $751,000
Q1 2023 May 15, 2023	BUY	$7.36 - $12.72 $288,070 - $497,860	39,140 Added 19.15%	243,525 $1.95 Million
Q4 2022 Feb 14, 2023	SELL	$7.02 - $9.76 $118,595 - $164,885	-16,894 Reduced 7.63%	204,385 $1.85 Million
Q3 2022 Nov 14, 2022	SELL	$5.33 - $11.3 $462,105 - $979,698	-86,699 Reduced 28.15%	221,279 $1.53 Million
Q2 2022 Aug 15, 2022	BUY	$4.66 - $13.96 $1.13 Million - $3.4 Million	243,238 Added 375.72%	307,978 $1.69 Million
Q1 2022 May 16, 2022	BUY	$11.89 - $24.68 $769,758 - $1.6 Million	64,740 New	64,740 $834,000
Q4 2021 Feb 14, 2022	SELL	$24.14 - $35.18 $632,878 - $922,314	-26,217 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.38 - $42.21 $717,821 - $1.11 Million	26,217 New	26,217 $866,000
Q2 2021 Aug 13, 2021	SELL	$26.34 - $46.62 $139,470 - $246,852	-5,295 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$45.96 - $68.02 $198,547 - $293,846	-4,320 Reduced 44.93%	5,295 $268,000
Q4 2020 Feb 16, 2021	BUY	$13.72 - $51.57 $131,917 - $495,845	9,615 New	9,615 $467,000
Q1 2020 May 15, 2020	SELL	$9.63 - $17.14 $59,407 - $105,736	-6,169 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.2 - $13.2 $693,259 - $1.27 Million	-96,286 Reduced 93.98%	6,169 $81,000
Q3 2019 Nov 14, 2019	BUY	$8.95 - $15.72 $326,469 - $573,418	36,477 Added 55.29%	102,455 $918,000
Q2 2019 Aug 14, 2019	BUY	$14.61 - $22.45 $448,833 - $689,686	30,721 Added 87.13%	65,978 $1.05 Million
Q1 2019 May 14, 2019	BUY	$14.24 - $22.28 $502,059 - $785,525	35,257 New	35,257 $662,000
Q3 2018 Nov 14, 2018	SELL	$13.39 - $26.25 $1.04 Million - $2.05 Million	-77,930 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$15.0 - $25.6 $1.17 Million - $2 Million	77,930 New	77,930 $1.22 Million

Others Institutions Holding SRRK

# of Institutions

257

Shares Held

88.6M

Call Options Held

1.82M

Put Options Held

1.17M

View Full List

About Scholar Rock Holding Corp

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $1.9B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

More about SRRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Scholar Rock Holding Corp Transaction History